Showing results (51-60 of 387) with videos related to

Sort By:
Pageof 39
Journal of Molecular Neuroscience : MN|September 3, 2015
CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson DiseaseMark Terrelonge, Karen S Marder, Daniel Weintraub, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|February 14, 2006
Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson diseaseDaniel Weintraub, Katherine A Oehlberg, Ira R Katz, et al.
Parkinsonism & Related Disorders|November 22, 2019
Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodiesSarah Horn, Hayley Richardson, Sharon X Xie, et al.
Clinical Parkinsonism & Related Disorders|April 10, 2025
Impact of pimavanserin on prescribing practices in parkinson diseaseThanh Phuong Pham Nguyen, Vy Le, Daniel Weintraub, et al.
Neurology|August 17, 2014
Course of psychiatric symptoms and global cognition in early Parkinson diseasePatricia de la Riva, Kara Smith, Sharon X Xie, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
Impulse control disorders in Parkinson's disease: a national Swedish registry study on high-risk treatments and vulnerable patient groupsMirjam Wolfschlag, Gustav Cedergren Weber, Daniel Weintraub, et al.
Frontiers in Physiology|December 29, 2011
Identification of behavioral and metabolic factors predicting adiposity sensitivity to both high fat and high carbohydrate diets in ratsPatrick Christian Even, Nachiket A Nadkarni, Catherine Chaumontet, et al.
Plos One|January 14, 2017
Impact of Orexin-A Treatment on Food Intake, Energy Metabolism and Body Weight in MiceAnne Blais, Gaëtan Drouin, Catherine Chaumontet, et al.
Parkinsonism & Related Disorders|February 3, 2009
Involuntary emotional expression disorder (IEED) in Parkinson's diseaseLisa Phuong, Shalini Garg, John E Duda, et al.
The Lancet. Neurology|November 22, 2016
Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort studyAnette Schrag, Uzma Faisal Siddiqui, Zacharias Anastasiou, et al.
Pageof 39